ALPS ADVISORS INC - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$2,014,000
+92.4%
38,984
-7.7%
0.02%
+90.0%
Q2 2022$1,047,000
-42.6%
42,238
-42.0%
0.01%
-50.0%
Q1 2022$1,825,000
-38.2%
72,802
-10.2%
0.02%
-39.4%
Q4 2021$2,951,000
+101.4%
81,040
-5.4%
0.03%
+135.7%
Q3 2021$1,465,000
+19.1%
85,678
-6.7%
0.01%
+27.3%
Q2 2021$1,230,000
-80.9%
91,864
-27.1%
0.01%
-82.5%
Q1 2021$6,453,000
-16.3%
125,942
+1.1%
0.06%
-27.6%
Q4 2020$7,710,000
+60.2%
124,523
+41.7%
0.09%
+22.5%
Q3 2020$4,814,000
-0.8%
87,853
+4.1%
0.07%
+9.2%
Q2 2020$4,855,000
+14.4%
84,380
-20.1%
0.06%
-1.5%
Q1 2020$4,245,000
-8.5%
105,638
-9.9%
0.07%
+83.3%
Q4 2019$4,639,000
+489.5%
117,288
+1.0%
0.04%
+500.0%
Q3 2019$787,000
-30.4%
116,109
-4.4%
0.01%
-25.0%
Q2 2019$1,130,000
-33.3%
121,493
-0.4%
0.01%
-33.3%
Q1 2019$1,695,000
-0.8%
122,039
-22.0%
0.01%
-7.7%
Q4 2018$1,708,000
+3.2%
156,559
+19.6%
0.01%
+18.2%
Q3 2018$1,655,000
+17.2%
130,929
+22.1%
0.01%
+22.2%
Q2 2018$1,412,000
+176.3%
107,231
+185.3%
0.01%
+125.0%
Q1 2018$511,000
+70.9%
37,591
-8.6%
0.00%
+100.0%
Q1 2017$299,000
-12.1%
41,127
-10.5%
0.00%
-33.3%
Q4 2016$340,00045,9420.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q1 2019
NameSharesValueWeighting ↓
Tri Locum Partners LP 296,327$7,429,0002.90%
Integral Health Asset Management, LLC 400,000$10,028,0002.61%
Cormorant Asset Management, LP 865,000$21,686,0001.66%
HealthCor Management, L.P. 956,740$23,985,0001.60%
Sofinnova Investments, Inc. 573,684$14,382,0001.09%
Lisanti Capital Growth, LLC 321,569$8,062,0000.91%
Cahill Wealth Management, LLC 44,913$1,125,0000.84%
Perceptive Advisors 1,655,079$41,493,0000.83%
RA Capital Management 1,155,964$28,980,0000.63%
Avidity Partners Management LP 1,175,000$29,457,0000.61%
View complete list of CHEMOCENTRYX INC shareholders